Relationship of COVID-19 with Polycystic Ovary Syndrome

This study shows that there is a significant relationship between the metabolic pathology Polycystic Ovary Syndrome (PCOS) and the level of severity of COVID-19 (NG C-19). The sample consisted of 600 women of different age groups ("adolescent", "young adult", "middle adult" and older adult"). [...] The statistical analysis related to PCOS and NG C-19 had the chi-square tests with a p < 0.05. Of the 600 women in the sample present a relationship between polycystic ovarian disease on ultrasound, with the level of severity COVID-19 and the diagnosis of COVID-19 by PCR: asymptomatic correspond to 8.30%, mild symptomatology to 53.30%, medium symptomatology to 55.60% and severe symptomatology to 66.70% and correspond to 22.50% of the total sample (CT 1); with the diagnosis of COVID-19 by Antigen-Antibody: asymptomatic patients accounted for 7.30%, those with mild symptomatology 63.30%, those with medium symptomatology 88.90% and those with severe symptomatology 33.30% and accounted for 25.40% of the total sample (CT 2)...

Autorentext

Spezialist für nationale Sicherheit und Entwicklung, IAEN, Ecuador. Spezialist für Lehrplangestaltung durch Kompetenz, UDM, Chile. Magister in Epidemiologie und kollektiver Gesundheit, UASB, Ecuador. Doktortitel in Medizinischen Wissenschaften, LUZ, Venezuela. Dozentin und Mitglied des Akademischen Ausschusses der Fakultät für Medizinische Wissenschaften, ULEAM.